Tevogen Bio Holdings Inc. — Director's Dealing 2024

Dec 26, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tevogen Bio Holdings Inc. (TVGN)
CIK: 0001860871
Period of Report: 2024-12-23

Reporting Person: Goh Keow Lin (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-23	Common Stock	A	240000	$0.00	Acquired	433923	Direct

Footnotes

F1: Represents a grant of restricted stock units ("RSUs") under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in four equal annual installments beginning on January 1, 2025, provided that the reporting person remains in service with the Issuer at such dates. Each RSU represents a contingent right to receive one share of the Issuer's common stock.